INTRODUCTION AND OBJECTIVES: 68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) has become a common method for primary staging of prostate cancer in Europe. However, 18F-labeled PSMA ligands are increasingly being used owing to their favorable half-life, large batch production and lower positron range compared with 68Ga-labeled counterparts. Radiohybrid PSMA (rhPSMA) ligands are a new class of theranostic PSMA-targeting agents that feature the fast synthesis associated with 18F while allowing labeling with radiometals. This retrospective analysis investigates the efficacy of 18F-rhPSMA7 PET for primary N-staging of prostate cancer compared with histopathological findings.
INTRODUCTION AND OBJECTIVES:
There is considerable variance in the reported accuracy of Ga68-PSMA PET/CT (PSMA PET/ CT) and multiparametric MRI (mpMRI) for regional staging of prostate cancer (PCa). We estimated the negative predictive value of these modalities in patients who underwent radical prostatectomy.
METHODS: A multicenter cohort of patients who underwent PET/CT and MRI prior to radical prostatectomy was analyzed. All patients underwent standard pelvic lymph node dissection. Increased Ga68-PSMA uptake on PET/CT and enlarged (>10 mm) lymph nodes (LN) on MRI were considered positive findings. The final surgical pathology served as standard of reference. The negative predictive value (NPV) was calculated for each modality separately as well as the combined. Due to inherent selection bias, the positive predictive value was not calculated.
RESULTS: 58 patients with intermediate or high risk PCa were included. The median PSA level was 8.5 ng/ml (IQR: 5.7-14.2). Preoperative grade group was 4 or 5 in 26 patients (44%), 3 in 14 patients (24%), 2 in 17 patients (30%) and 1 in one patient (2%). The median number of extracted LN was 11 (IQR: 6-18). Metastatic LN involvement was found in 11 patients (19%). A single positive node was found in 7/11 patients (64%).
The median maximal diameter of the involved LN and the median intra nodal tumor diameter were 6 mm (IQR: 3.5-10) and 1 mm (IQR: 1-3) mm, respectively.
The Negative predictive value of PET/CT, MRI, and the two tests combined were 82.3%, 81.8%, and 83.6%, respectively.
CONCLUSIONS: Ga68-PSMA PET/CT and multiparametric MRI demonstrated similar performance in excluding pelvic lymph nodes metastases with NPV of approximately 82%. Combination of both tests did not improve the negative predictive value significantly. Our results reinforce the need for pelvic lymph nodes dissection in order to achieve accurate staging. 
Despite the curative intent of radical prostatectomy(RP) for localized prostate cancer, many patients experience biochemical recurrence(BCR). We report sitespecific relapse patterns of post-prostatectomy patients with BCR assessed by 68Ga-PSMA-11 or 11C-Choline PET/CT and investigated the impact of postoperative androgen deprivation therapy(ADT) and radiotherapy(RT) on the anatomic distribution of relapse. METHODS: We identified 243 patients with BCR after RP with at least one positive lesion on 68Ga-PSMA-11 or 11C-Choline PET/CT between 2010 and 2017 at a single tertiary referral center. Positive lesions were mapped as local, nodal, skeletal or visceral recurrence (Table 1) . Patients were categorized according to postoperative RT and ADT treatment in 3 subgroups (RT, ADT and RTþADT) and compared with the reference group (no ADT or RT). Non-parametrical tests were used and overall patterns of relapse were described using frequencies and percentages.
RESULTS: 192 (79%) patients were evaluated with 68Ga-PSMA-11 PET/CT and 51 (21%) with 11C-Choline PET/CT. Median PSA at the time of imaging was 1.4, 2.9, 1.9 and 1.1 ng/ml in the RT, ADT, RTþADT and reference group, respectively (p[0.17) . Patients in the ADT group had less nodal recurrence compared with the reference group (53.1%vs 79.4%; p[0.02) . No statistically significant difference in skeletal recurrence was found between any subgroup and the reference group, although patients treated with ADT had a greater tendency towards having bone metastases. Patients in the reference group had no local relapse compared with 31.2% in the ADT group.
CONCLUSIONS: The relapse pattern of post-prostatectomy patients with BCR is significantly affected by postoperative ADT and/ or RT. Patients with BCR following RP or RPþRT have a relapse
